| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thomas Mathews, Yekeen A. Aderibigb. Proposed research diagnostic criteria for neuroleptic malignant syndrome. The international journal of neuropsychopharmacology. vol 2. issue 2. 2019-11-20. PMID:11281981. |
many sets of diagnostic criteria have been proposed for neuroleptic malignant syndrome (nms) but there is a lack of uniformity. |
2019-11-20 |
2023-08-12 |
Not clear |
| David A. Case. Electroconvulsive Therapy in the Neuroleptic Malignant Syndrome. Convulsive therapy. vol 3. issue 4. 2019-11-20. PMID:11940929. |
a case of neuroleptic malignant syndrome (nms) successfully treated with electroconvulsive therapy (ect) is presented and the literature on this subject is summarized. |
2019-11-20 |
2023-08-12 |
human |
| D. P. Devanand, Harold A. Sackeim, A. Donald Finc. Modified ECT Using Succinylcholine After Remission of Neuroleptic Malignant Syndrome. Convulsive therapy. vol 3. issue 4. 2019-11-20. PMID:11940930. |
the authors report two patients with a history of neuroleptic malignant syndrome (nms) who were treated with ect using succinylcholine as muscle relaxant, without ensuing complications. |
2019-11-20 |
2023-08-12 |
Not clear |
| Stephan C. Mann, Stanley N. Caroff, Henry R. Bleier, R. Eduardo Antelo, Hyong U. Electroconvulsive Therapy of the Lethal Catatonia Syndrome. Convulsive therapy. vol 6. issue 3. 2019-11-20. PMID:11941074. |
the use of ect in the treatment of neuroleptic malignant syndrome (nms), viewed here as a subtype of lc, is considered and compared with that of specific drug therapies for nms. |
2019-11-20 |
2023-08-12 |
Not clear |
| John M. Davis, Philip G. Janicak, Paul Sakkas, Cindy Gilmore, Zhengyu Wan. Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome. Convulsive therapy. vol 7. issue 2. 2019-11-20. PMID:11941110. |
in a review of 734 published cases of neuroleptic malignant syndrome (nms), we found 665 with sufficient data to allow statistical analyses. |
2019-11-20 |
2023-08-12 |
Not clear |
| William A. Scheftner, Robert B. Shulma. Treatment Choice in Neuroleptic Malignant Syndrome. Convulsive therapy. vol 8. issue 4. 2019-11-20. PMID:11941178. |
a literature review of patients with symptomatic neuroleptic malignant syndrome (nms) treated with electroconvulsive therapy (ect) yielded 26 cases, to which we add five cases. |
2019-11-20 |
2023-08-12 |
Not clear |
| Bella Hanin, Yaacov Lerne. Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy. Convulsive therapy. vol 9. issue 3. 2019-11-20. PMID:11941213. |
the necessity of neuroleptic rechallenge in patients who have experienced neuroleptic malignant syndrome (nms) has been discussed in recent articles. |
2019-11-20 |
2023-08-12 |
Not clear |
| M. Samir Arnaout, Fouad P. Antun, Khalil Ashka. Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia. Human psychopharmacology. vol 16. issue 3. 2019-11-20. PMID:12404581. |
on admission, typical neuroleptic malignant syndrome (nms) developed with elevated body temperature (39.7 degrees c), obtundation, tremor, rigidity, diaphoresis, fluctuating pupillary diameter, tachycardia, labile hypertension, elevated serum creatine kinase and severe hypernatremia (190 meq/l). |
2019-11-20 |
2023-08-12 |
Not clear |
| Loopinder Sood, Andy Owen, Mandeep Sain. Olanzapine-induced rhabdomyolysis. Irish journal of psychological medicine. vol 23. issue 3. 2019-11-20. PMID:30290514. |
we present a case of possible olanzapine-induced rhabdomyolysis in the absence of other features of neuroleptic malignant syndrome (nms). |
2019-11-20 |
2023-08-13 |
Not clear |
| Maria Fernanda Escobar-Vidarte, Sara Loaiza-Osorio, Adriana A Messa, Gloria Elena Macía. Neuroleptic malignant syndrome in pregnancy: case report and literature review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. vol 32. issue 14. 2019-10-14. PMID:29363376. |
neuroleptic malignant syndrome (nms) is a serious complication associated with the use of drugs that affect dopaminergic system neurotransmission. |
2019-10-14 |
2023-08-13 |
Not clear |
| Divyani Garg, Varun Reddy, Rajesh Kumar Singh, Deepa Dash, Rohit Bhatia, Manjari Tripath. Neuroleptic malignant syndrome as a presenting feature of subacute sclerosing panencephalitis. Journal of neurovirology. vol 24. issue 1. 2019-10-03. PMID:29243130. |
we describe a case of sspe presenting with extensive rigidity with highly elevated cpk values, mimicking neuroleptic malignant syndrome (nms) which was most probably due to central dopaminergic blockade induced by the disease process. |
2019-10-03 |
2023-08-13 |
Not clear |
| D Hirjak, A Sartorius, K M Kubera, R C Wol. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome]. Der Nervenarzt. vol 90. issue 1. 2019-08-30. PMID:30128733. |
the two most severe complications are antipsychotic-associated catatonic symptoms (acs) and neuroleptic malignant syndrome (nms). |
2019-08-30 |
2023-08-13 |
Not clear |
| N A Uvai. Atypical neuroleptic malignant syndrome (NMS). Asian journal of psychiatry. vol 30. 2019-08-27. PMID:28892745. |
atypical neuroleptic malignant syndrome (nms). |
2019-08-27 |
2023-08-13 |
Not clear |
| N A Uvais, Prathosh Gangadhar, V S Sreeraj, P A Rafeequ. Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion. Asian journal of psychiatry. vol 41. 2019-08-13. PMID:29174670. |
neuroleptic malignant syndrome (nms) associated with amisulpride and sertraline use: a case report and discussion. |
2019-08-13 |
2023-08-13 |
Not clear |
| Saki Manabe, Hidetaka Yanagi, Hideki Ozawa, Atsushi Takag. Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease. BMJ case reports. vol 12. issue 2. 2019-06-11. PMID:30824461. |
thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (nms). |
2019-06-11 |
2023-08-13 |
Not clear |
| Clémentine Lantin, Miriam Franco, François-Xavier Dekeuleneer, Didier Chamart, Juan Martin Tecc. Neuroleptic malignant syndrome in a patient treated with clotiapine. Psychiatria Danubina. vol 30. issue Suppl 7. 2019-06-05. PMID:30439816. |
neuroleptic malignant syndrome (nms), which is linked to the use of antipsychotic medication, is a potentially lethal neurological emergency. |
2019-06-05 |
2023-08-13 |
Not clear |
| N Wystub, S Heymel, M Fritzenwanger, P C Schulze, R Pfeife. [Prolonged neuroleptic malignant syndrome after Haloperidol injection]. Medizinische Klinik, Intensivmedizin und Notfallmedizin. vol 113. issue 3. 2019-05-30. PMID:28752347. |
neuroleptic malignant syndrome (nms) is a rare disorder caused by drug-induced dopamine-receptor-blockage or low dopamine concentration in the brain. |
2019-05-30 |
2023-08-13 |
Not clear |
| b' Mehmet Osman Ak\\xc3\\xa7akaya, Nihan Hande Ak\\xc3\\xa7akaya, Mustafa \\xc3\\x96m\\xc3\\xbcr Kas\\xc4\\xb1mcan, Talat K\\xc4\\xb1r\\xc4\\xb1\\xc5\\x9. Life-threatening parkinsonism-hyperpyrexia syndrome following bilateral deep brain stimulation of the subthalamic nucleus. Neurologia i neurochirurgia polska. vol 52. issue 2. 2019-05-24. PMID:29233537.' |
parkinsonism-hyperpyrexia syndrome (phs), or neuroleptic malignant syndrome (nms), is a neurophysiologic reaction to the acute withdrawal/decrease of central dopamine levels. |
2019-05-24 |
2023-08-13 |
Not clear |
| R Knorr, J Schöllkopf, E Hae. [Neuroleptic malignant syndrome]. Der Nervenarzt. vol 89. issue 3. 2019-05-23. PMID:29209753. |
neuroleptic malignant syndrome (nms) is a rare but severe undesired complication of psychopharmacological treatment. |
2019-05-23 |
2023-08-13 |
Not clear |
| Harsh Sahu, Mouna Bidarguppe Manjunath, Animesh Ray, Naval Kishore Vikra. Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association. BMJ case reports. vol 11. issue 1. 2019-04-03. PMID:30567175. |
clinical features are similar to that of neuroleptic malignant syndrome (nms) like hyperthermia, autonomic dysfunction, altered sensorium, muscle rigidity; but instead of history of neuroleptic use, there is history of withdrawal of dopaminergic drugs. |
2019-04-03 |
2023-08-13 |
Not clear |